Structure and repair of replication-coupled DNA breaks.


Journal

Science (New York, N.Y.)
ISSN: 1095-9203
Titre abrégé: Science
Pays: United States
ID NLM: 0404511

Informations de publication

Date de publication:
20 Jun 2024
Historique:
medline: 20 6 2024
pubmed: 20 6 2024
entrez: 20 6 2024
Statut: aheadofprint

Résumé

Using CRISPR/Cas9 nicking enzymes, we examine the interaction between the replication machinery and single strand breaks, one of the most common forms of endogenous DNA damage. We show that replication fork collapse at leading strand nicks generates resected single-ended double-strand breaks (seDSBs) that are repaired by homologous recombination (HR). If these seDSBs are not promptly repaired, arrival of adjacent forks creates double ended DSBs (deDSBs), which could drive genomic scarring in HR-deficient cancers. deDSBs can also be generated directly when the replication fork bypasses lagging strand nicks. Unlike deDSBs produced independently of replication, end-resection at nick-induced se/deDSBs is BRCA1-independent. Nevertheless, BRCA1 antagonizes 53BP1 suppression of RAD51 filament formation. These results highlight unique mechanisms that maintain replication fork stability.

Identifiants

pubmed: 38900911
doi: 10.1126/science.ado3867
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

eado3867

Auteurs

Raphael Pavani (R)

Laboratory of Genome Integrity, National Cancer Institute, NIH, Bethesda, MD, USA.

Veenu Tripathi (V)

Laboratory of Genome Integrity, National Cancer Institute, NIH, Bethesda, MD, USA.

Kyle B Vrtis (KB)

Department of Biological Chemistry and Molecular Pharmacology, Blavatnik Institute, Harvard Medical School, Blavatnik Institute, Boston, MA, USA.

Dali Zong (D)

Laboratory of Genome Integrity, National Cancer Institute, NIH, Bethesda, MD, USA.

Raj Chari (R)

Genome Modification Core, Frederick National Lab for Cancer Research, Frederick, MD, USA.

Elsa Callen (E)

Laboratory of Genome Integrity, National Cancer Institute, NIH, Bethesda, MD, USA.

Ajith V Pankajam (AV)

Laboratory of Genome Integrity, National Cancer Institute, NIH, Bethesda, MD, USA.

Gang Zhen (G)

Laboratory of Genome Integrity, National Cancer Institute, NIH, Bethesda, MD, USA.

Gabriel Matos-Rodrigues (G)

Laboratory of Genome Integrity, National Cancer Institute, NIH, Bethesda, MD, USA.

Jiajie Yang (J)

State Key Laboratory of Molecular Biology, Shanghai Institute of Biochemistry and Cell Biology, Center for Excellence in Molecular Cell Science, Chinese Academy of Sciences, Shanghai, China.

Shuheng Wu (S)

State Key Laboratory of Molecular Biology, Shanghai Institute of Biochemistry and Cell Biology, Center for Excellence in Molecular Cell Science, Chinese Academy of Sciences, Shanghai, China.

Giordano Reginato (G)

Institute for Research in Biomedicine, Universita della Svizzera italiana (USI), Faculty of Biomedical Sciences, Bellinzona, 6500, Switzerland.

Wei Wu (W)

State Key Laboratory of Molecular Biology, Shanghai Institute of Biochemistry and Cell Biology, Center for Excellence in Molecular Cell Science, Chinese Academy of Sciences, Shanghai, China.

Peter Cejka (P)

Institute for Research in Biomedicine, Universita della Svizzera italiana (USI), Faculty of Biomedical Sciences, Bellinzona, 6500, Switzerland.

Johannes C Walter (JC)

Department of Biological Chemistry and Molecular Pharmacology, Blavatnik Institute, Harvard Medical School, Blavatnik Institute, Boston, MA, USA.
Howard Hughes Medical Institute, Harvard University, Boston, MA, USA.

André Nussenzweig (A)

Laboratory of Genome Integrity, National Cancer Institute, NIH, Bethesda, MD, USA.

Classifications MeSH